Empirical Comparative Study of Variation Blood Level Antibody Vitamin D at Scleroderma (SSc) Patients Compared Healthy Peoples

Clalit Health Services

Status: Unknown

Conditions: Scleroderma

Treatments: Other: Blood sample

Study type: Interventional

Funder types: Other

Identifiers

NCT01553890

vitamin D and Scleroderma

Details and patient eligibility

About

The aim is to find the presence of anti vitamin D antibodies in scleroderma patients and compare with control. A second goal is anti vitamin D levels in serum of scleroderma patients in relation to the clinical manifestations of the disease.

Full description

Blood samples from 30 scleroderma patients compared to 30 healthy peoples to reach the target of variation of the blood level vitamin D antibody between this groups

Enrollment: 30 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

study group

1. patients with SSc
2. age - 18 years old and older
3. sign ICF control group - healthy people

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

30 participants in 2 patient groups

Patients diagnosed with scleroderma

Other group

Description:

patients diagnosed with scleroderma, clinical and lab support

Treatment:

Other: Blood sample

No disease

Other group

Description:

Blood sample, venous blood, about 10 ml will be drawn from participants

Treatment:

Other: Blood sample